Evidence map›Paper›PMID 42818508›Full record

ArticlebioRxiv : the preprint server for biology2026

Mechanosignaling promotes macrophage apoptosis resistance in pulmonary fibrosis

Chao He, Cristian Coarfa, Neftali Garcia, Olubunmi C Lebimoyo, Haiwei Gu, Elisa Ruiz-Echartea, Xiaoli Ji, Alan Waich, Juan D Zuluaga, Lindsay J Celada and 8 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Chao HeSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Cristian CoarfaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
Neftali GarciaSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Olubunmi C LebimoyoSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Haiwei GuCollege of Health Solutions, Arizona State University, Phoenix, AZ.
Elisa Ruiz-EcharteaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
Xiaoli JiSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Alan WaichSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Juan D ZuluagaSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Lindsay J CeladaSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Scott A OchsnerDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
Neil J McKennaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
Jennifer L Larson-CaseyDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL.
Sandeep K AgarwalSection of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX.
Farrah KheradmandSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.
Yong ZhouDivision of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University, New Orleans, LA.
A Brent CarterDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL.
Ivan O RosasSection of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX.

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
UM1HG006348: Cas9 Genome Integrity Supplemental ProposalUM1HG006348 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney, Chih-Wei Logan Hsu · 2016 to 2026
$47.5M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag · 2001 to 2026
$28.3M
Project 5: Pyolytic conversion of PAHs in contaminated sediments into char to eliminate toxicity and enhance soil fertilityP42ES027725 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Nagireddy Putluri · 2020 to 2026
$17.8M
Consortium for Translational and Precision HealthUM1TR004539 · NCATS · BAYLOR COLLEGE OF MEDICINE · PI Bettina M. Beech, FASIHA KANWAL · 2024 to 2026
$17.1M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Noradrenergic mechanisms in breathing and respiratory pathophysiologiesR01HL130249 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI RAY, RUSSELL S · 2016 to 2024
$5.3M
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITYR01DK114356 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2017 to 2025
$4.6M
Mechano-niche in Lung Repair after InjuryR01HL156973 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHOU, YONG · 2021 to 2024
$2.4M
Macrophage-fibroblast interaction is required for asbestos-induced toxicityR01HL175661 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI A BRENT CARTER · 2024 to 2026
$1.6M
UNDERSTANDING CADHERIN-11 IN THE DEVELOPMENT AND TREATMENT OF LUNG FIBROSISR01AR082635 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI Sandeep K Agarwal · 2024 to 2026
$1.6M
The Desmosome-Keratin Intermediate Filament Network in Lung Epithelial Injury, Repair and RegenerationR01HL174994 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI YONG ZHOU · 2025 to 2026
$1.4M
NCATS NIH HHS UM1 TR004539NCI NIH HHS P30 CA125123NHGRI NIH HHS UM1 HG006348NHLBI NIH HHS K08 HL163406NHLBI NIH HHS R01 HL130249NHLBI NIH HHS R01 HL156973NHLBI NIH HHS R01 HL174994NHLBI NIH HHS R01 HL175661NHLBI NIH HHS R01 HL176770NIAMS NIH HHS R01 AR082635NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK114356NIEHS NIH HHS P30 ES030285NIEHS NIH HHS P42 ES027725NIH HHS S10 OD030414NIH HHS S10 OD032185NIH HHS S10 OD036427
6 · The paper itself

Abstract

The mechanisms underlying disease progression in idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases remain unclear. Increased extracellular matrix stiffness is a hallmark of fibrotic lung diseases, while monocyte-derived macrophages promote fibrosis progression. However, there is limited understanding if mechanical properties of the fibrotic microenvironment influence macrophage phenotypes and fibrogenesis. Profibrotic macrophages are resistant to apoptosis, which is modulated by enhanced mitochondrial bioenergetics. The objective of this study is to determine how lung tissue stiffness impacts macrophage phenotypes and fibrotic progression. We demonstrate that mechanoactivated macrophages exhibit apoptosis-resistance, increased expression of the antiapoptotic protein Bcl-xL, and elevated mitochondrial oxidative phosphorylation. Critically, the metabolic reprogramming observed in mechanoactivated macrophages is dependent on increased glutaminolysis. Inhibition of glutaminolysis attenuated apoptosis resistance in mechanoactivated macrophages. Moreover, inhibition of Bcl-xL

Identifiers

PMID42818508
PMCPMC13622473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.